Respond to Specific Concerns
HOW TO
Raised by the treatment facility
If the Facility is Concerned About:
Back to:
Facilities that are willing to consider accepting a person with a bleeding disorder (BD) may need help thinking creatively about the ways in which they can safely and comfortably accommodate a person who uses infusion or injection medications. This section provides responses to concerns that may be raised by behavioral health treatment facilities:
If the facility is concerned about Medical Complexity:
If the facility says that bleeding disorders are “too medically complex” or denies your patient on the basis of “medical complexity” then cite MASAC Document 289.
“Our country’s national experts in bleeding disorders issued a national statement that if a person with a bleeding disorder is stable and has an established treatment protocol from a hematologist, the daily, ongoing management of the condition is straightforward and not complex, and should not be a reason for denying them access to treatment. My patient is medically stable and as long as you permit them to stay on their bleeding disorder medication while admitted, they are not actually medically complex, and their bleeding disorder should not be a reason for exclusion from care.”
“I am happy to send you the national recommendation from that National Bleeding Disorder Foundation’s Medical and Scientific Advisory Council (MASAC) approved October 2024 and walk you through it.”
Document 289
“The Medical and Scientific Advisory Council (MASAC) to the National Bleeding Disorders Foundation has weighed in on this issue and clarified in Document 289 that a stable, well managed person with a BD should have access to any residential or inpatient behavioral health treatment facility. ‘The presence of an underlying bleeding disorder alone does not make a patient medically unfit or medically unstable and should not preclude them from admission to a mental health or a substance use disorder treatment facility.’”
This national recommendation provides guidelines for mental health and/or substance use disorder facilities in conducting unbiased individualized assessments of people with bleeding disorders and determining whether individuals are appropriate for admission to a mental health and/or a substance use disorder treatment facility from a bleeding disorders perspective. It also provides recommendations to the bleeding disorder treatment team to support people with bleeding disorders in gaining access to appropriate mental health and/or a substance use disorder treatment facilities.”
https://static1.squarespace.com/static/6437fdd02ff49650233fa4aa/t/650202c427afed5addc20870/1694630596231/MASAC+stmt+279+substance+use+disorder+treatment.pdf